Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incannex Healthcare (IXHL) Cash from Operations (2022 - 2025)

Incannex Healthcare's Cash from Operations history spans 3 years, with the latest figure at 4637000.0 for Q4 2025.

  • On a quarterly basis, Cash from Operations rose 18.25% to 4637000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 18441000.0, a 16.57% decrease, with the full-year FY2025 number at 12513000.0, up 20.8% from a year prior.
  • Cash from Operations hit 4637000.0 in Q4 2025 for Incannex Healthcare, up from 9163000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for IXHL hit a ceiling of 1482000.0 in Q2 2025 and a floor of 9163000.0 in Q3 2025.
  • Historically, Cash from Operations has averaged 4211300.0 across 3 years, with a median of 3974000.0 in 2024.
  • Biggest five-year swings in Cash from Operations: surged 61.73% in 2024 and later plummeted 316.5% in 2025.
  • Tracing IXHL's Cash from Operations over 3 years: stood at 2103000.0 in 2023, then crashed by 169.71% to 5672000.0 in 2024, then rose by 18.25% to 4637000.0 in 2025.
  • Business Quant data shows Cash from Operations for IXHL at 4637000.0 in Q4 2025, 9163000.0 in Q3 2025, and 1482000.0 in Q2 2025.